NCT01313689 2018-11-08Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic LeukemiaNovartisPhase 3 Completed122 enrolled 24 charts
NCT01520922 2017-01-19Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)NovartisPhase 2 Completed99 enrolled 27 charts